Abstract

Simulations Plus, in partnerships with pharmaceutical companies globally, has made significant investments in its ADMET Predictor® platform to implement workflows which ‘think like a chemist’ and improve legacy screening approaches through the integration of machine learning and PBPK modeling.

In this 2-part webinar series, learn how you can apply our advanced cheminformatics toolkits and best-in-class ADMET property prediction models, with our novel, high-throughput PBPK calculations at the discovery/development interface, to support compound design and screening activities. And, get a sneak peek at the new Artificial Intelligence-driven Drug Design (AIDD) functionality coming in ADMET Predictor® X!

By Michael Lawless & David Miller